Cardiac Motion and its Impact on Target Coverage During SBRT for Refractory Ventricular Tachycardia.

Abstract

PURPOSE/OBJECTIVE(S)\nRefractory ventricular tachycardia (VT) is a common cause of death and morbidity in the heart failure population. Stereotactic body radiation therapy (SBRT) is a new and promising approach to treating VT, but there are practical concerns about SBRT delivery to the heart, which undergoes motion from both cardiac and respiratory cycles. In this study, we investigate motion magnitudes from both cycles and their impact on treatment margins and target coverage for VT SBRT.\n\n\nMATERIALS/METHODS\nTwenty-one patients were treated with SBRT for VT at our institution between April 2018 and December 2020 under an IRB-approved registry protocol. All patients had respiratory-correlated 4DCT for treatment planning and 7 patients had diagnostic cardiac-gated CT scans taken less than two weeks prior to treatment. Target structures were delineated on free-breathing CT and transferred to respiratory average (RAVG) CT via rigid registration. Dose was initially calculated on the RAVG per current institutional standard of care. For this retrospective study, deformable image registration (DIR) was applied between RAVG and the cardiac average CT (CAVG), systolic, and diastolic CTs from the cardiac dataset. Target contours were transferred to the registration target image. Motion magnitudes and distributions from the deformation vector fields were analyzed. Internal target volumes (ITVs) were created on the respiratory average images for quantitative analysis of target motion and coverage changes. From these 7 patients, 11 distinct target volumes were treated, with 8 being epicardial and 3 endocardial. Motion and dosimetry for all 11 targets were analyzed separately.\n\n\nRESULTS\nThe average (SD) target shift magnitudes (in mm) from the RAVG to CAVG CTs were 2.0 ± 1.0, 2.0 ± 1.3, and 4.0 ± 2.0 in the left-right (LR), anterior/posterior (AP), and superior/inferior (SI) directions. Endocardial targets had greater motion magnitude than epicardial targets, with mean shifts of 2.2 ± 1.0, 2.3 ± 1.9, and 4.2 ± 2.4 in the LR, AP, and SI directions versus 1.4 ± 0.9, 1.3 ± 0.8, and 3.6 ± 0.5. Cardiac cycle motion showed more variability for epicardial targets with shifts of 1.4 ± 2.5, 2.4 ± 3.0, and 2.5 ± 3.7 in the LR, AP and SI directions, versus 2.0 ± 0.6, 2.1 ± 0.8, and 1.6 ± 0.7 for endocardial targets. Creation of motion encompassing ITVs led to an average target size increase of 100% (25 cm3). V95 for initial target volumes was 99.9 ± 0.4% while the average V95 for ITVs was 84.1 ± 15.6%. Similarly, D95 for the target dropped from 108.2 ± 5.7% to 75.3 ± 28.4%.\n\n\nCONCLUSION\nIn this cohort of patients undergoing SBRT for VT, cardiac shifts were location-dependent and were largest in the SI direction. These shifts typically exceeded the 1-5 mm margins used for SBRT treatment planning and ITV generation to encompass all target motion led to a doubling in target size. Our data suggest that cardiac-gated delivery may be helpful to minimize treatment volumes and spare cardiac tissue.